Characteristics | Fazekas scale | Statistical value | p value | |||
Grade 0 | Grade I | Grade II | Grade III | |||
Total number (n) | 44 | 79 | 44 | 36 | - | - |
Age (years; mean ± SD) | 61.02 ± 7.9 | 66.97 ± 11.1 | 71.75 ± 10.82 | 76.14 ± 8.1 | 22.886 | 0.006 |
Male/female | 25/19 | 40/39 | 22/22 | 10/26 | 7.558 | 0.056 |
Smoking history | 43.2% | 36.7% | 29.5% | 25.0% | 3.5555 | 0.314 |
Hypertension | 70.5% | 72.2% | 79.5% | 83.3% | 2.656 | 0.448 |
Diabetes | 31.8% | 35.4% | 38.6% | 33.3% | 0.502 | 0.918 |
Coronary heart disease | 15.9% | 4.2% | 34.1% | 61.1% | 17.883 | 0.000 |
Stroke history | 27.3% | 31.6% | 52.3% | 58.3% | 13.080 | 0.004 |
Total cholesterol (mmol/L) | 4.84 ± 1.35 | 4.56 ± 1.37 | 4.08 ± 1.07 | 4.55 ± 1.21 | 6.502 | 0.090 |
Triglyceride (mmol/L) | 2.44 ± 1.99 | 2.06 ± 0.93 | 2.00 ± 0.73 | 1.95 ± 0.85 | 2.106 | 0.551 |
Low-density lipoprotein (mmol/L) | 3.50 ± 1.02 | 3.56 ± 1.12 | 3.30 ± 0.79 | 3.60 ± 0.92 | 2.251 | 0.522 |
High-density lipoprotein (mmol/L) | 1.33 ± 0.43 | 1.21 ± 0.42 | 1.35 ± 0.46 | 1.28 ± 0.42 | 3.527 | 0.317 |
Apolipoprotein A/B | 1.09 ± 0.57 | 0.93 ± 1.84 | 0.97 ± 0.13 | 0.98 ± 0.34 | 3.606 | 0.307 |
Apolipoprotein A1 (mg/L) | 0.87 ± 0.44 | 0.86 ± 0.07 | 0.87 ± 0.52 | 0.87 ± 0.59 | 1.553 | 0.670 |
Glycosylated hemoglobin (%) | 6.33 ± 1.30 | 6.42 ± 1.43 | 6.22 ± 1.15 | 6.46 ± 1.53 | 0.902 | 0.825 |
Homocysteine (mmol/L) | 17.9 ± 8.63 | 19.5 ± 9.58 | 23.4 ± 22.8 | 22.5 ± 16.2 | 1.389 | 0.708 |